Money and Finance
I mentioned in my annual dividend growth checkup that I was underweight the health care industry and was looking to increase my exposure there. I recently added shares of one health care giant, Becton, Dickinson & Company (NYSE:BDX) (Full Analysis Here), to my portfolio; however, there's another giant that is absolutely wonderful. Johnson & Johnson (NYSE:JNJ) recently announced a 7.1% dividend increase which would mark its 53rd consecutive increase, marking JNJ as a dividend champion. Johnson & Johnson closed trading on Friday, May 1st at $101.13, giving a current yield of 2.97%.
- Now's Not The Time For Mccormick & Company, Inc.
I mentioned in my dividend growth checkup that my plan for the year was to allocate less capital to the consumer staples due to their general overvaluation. However, that doesn't mean that I won't identify excellent companies with large moats...
- Union Pacific Corporation: Keeping Your Portfolio On Track
As long as consumers continue to consume, Union Pacific (NYSE:UNP) will be there to ship goods across the country. Union Pacific Corporation is a dividend challenger with 8 consecutive years of dividend increases. Union Pacific closed trading on Friday,...
- Can Becton, Dickinson & Company Cure Your Portfolio?
To no one's surprise the health care industry has a long-term bullish thesis with the aging baby-boomer population advancing in age. Unfortunately, as we age we also tend to use more health care services. Becton, Dickinson and Company (NYSE:BDX) provides...
- Can Johnson & Johnson Cure What Ails Your Portfolio?
Johnson & Johnson (JNJ) is well known around the dividend growth investing community with over 50 consecutive years of dividend increases. Chances are there's Johnson & Johnson products in your medicine cabinet right now and if you've...
- A Closer Look At Johnson & Johnson (jnj)
As a stock holder of many different companies I find myself checking through all kinds news and analysis on the internet. This week I thought I'd share a couple of items about the Dividend Aristocrat Johnson & Johnson. Some fellow dividend bloggers...
Money and Finance
Johnson & Johnson: Quality at a Reasonable Price
I mentioned in my annual dividend growth checkup that I was underweight the health care industry and was looking to increase my exposure there. I recently added shares of one health care giant, Becton, Dickinson & Company (NYSE:BDX) (Full Analysis Here), to my portfolio; however, there's another giant that is absolutely wonderful. Johnson & Johnson (NYSE:JNJ) recently announced a 7.1% dividend increase which would mark its 53rd consecutive increase, marking JNJ as a dividend champion. Johnson & Johnson closed trading on Friday, May 1st at $101.13, giving a current yield of 2.97%.
The following tables/graphs are taken from my personal stock analysis spreadsheet. Data for the stock analysis was sourced from Johnson & Johnson's investor relations page, Morningstar, and Yahoo Finance.
Historic Growth Rates:
Historically, owners of Johnson & Johnson have earned solid returns. According to longrundata.com, JNJ has rewarded investors with a total return of 196%, or 7.0% annualized returns, over the last 10 years. Those numbers are market returns at specific snapshots in time and aren't necessarily indicative of the business results over the same time period. Looking at the historic growth rates for per share dividends, earnings, revenue, and free cash flow gives a better idea of the operational results that Johnson & Johnson has delivered.
You can read the full analysis of Johnson & Johnson on Seeking Alpha.
- Now's Not The Time For Mccormick & Company, Inc.
I mentioned in my dividend growth checkup that my plan for the year was to allocate less capital to the consumer staples due to their general overvaluation. However, that doesn't mean that I won't identify excellent companies with large moats...
- Union Pacific Corporation: Keeping Your Portfolio On Track
As long as consumers continue to consume, Union Pacific (NYSE:UNP) will be there to ship goods across the country. Union Pacific Corporation is a dividend challenger with 8 consecutive years of dividend increases. Union Pacific closed trading on Friday,...
- Can Becton, Dickinson & Company Cure Your Portfolio?
To no one's surprise the health care industry has a long-term bullish thesis with the aging baby-boomer population advancing in age. Unfortunately, as we age we also tend to use more health care services. Becton, Dickinson and Company (NYSE:BDX) provides...
- Can Johnson & Johnson Cure What Ails Your Portfolio?
Johnson & Johnson (JNJ) is well known around the dividend growth investing community with over 50 consecutive years of dividend increases. Chances are there's Johnson & Johnson products in your medicine cabinet right now and if you've...
- A Closer Look At Johnson & Johnson (jnj)
As a stock holder of many different companies I find myself checking through all kinds news and analysis on the internet. This week I thought I'd share a couple of items about the Dividend Aristocrat Johnson & Johnson. Some fellow dividend bloggers...